Response to the letter to the editor

被引：0

作者：

de Labry Lima, Antonio Olry ^{[1
,2
,3
]}

Fenix-Caballero, Silvia ^{[4
]}

Spacirova, Zuzana ^{[1
,2
,3
]}

del Rey, Emilio Jesus Alegre ^{[4
]}

机构：

[1] Escuela Andaluza Salud Publ, Ctr Andaluz Informac Medicamento CADIME, Granada, Spain

[2] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

[3] Inst Invest Biosanitaria Ibs, Granada, Spain

[4] Hosp Univ Puerto Real, Pharm Unit, Cadiz, Spain

来源：

BREAST | 2021年 / 60卷

关键词：

D O I：

10.1016/j.breast.2021.10.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：303 / 303

页数：1

共 5 条

[1] Quality of life with talazoparib versus physician's choice of chemotherapy in patients wits advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA ease III trial [J].

Ettl, J. ;

Quek, R. G. W. ;

Lee, K. -H. ;

Rugo, H. S. ;

Hurvitz, S. ;

Goncalves, A. ;

Fehrenbacher, L. ;

Yerushalmi, R. ;

Mina, L. A. ;

Martin, M. ;

Roche, H. ;

Im, Y. -H. ;

Markova, D. ;

Bhattacharyya, H. ;

Hannah, A. L. ;

Eiermann, W. ;

Blum, J. L. ;

Litton, J. K. .

ANNALS OF ONCOLOGY, 2018, 29 (09) :1939-1947

[2] Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain [J].

Lima, Antonio Olry de Labry ;

Spacirova, Zuzana ;

Fenix-Caballero, Silvia ;

Hoces, Antonio Matas ;

Vegas, Adrian Sanchez ;

Aranzana, Manuel Cardenas ;

Sierra-Sanchez, Jesus F. ;

Martinez Diaz, Maria del Carmen ;

del Rey, Emilio Jesus Alegre .

BREAST, 2021, 58 :27-33

[3] Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial [J].

Litton, J. K. ;

Hurvitz, S. A. ;

Mina, L. A. ;

Rugo, H. S. ;

Lee, K-H ;

Goncalves, A. ;

Diab, S. ;

Woodward, N. ;

Goodwin, A. ;

Yerushalmi, R. ;

Roch, H. ;

Im, Y-H ;

Eiermann, W. ;

Quek, R. G. W. ;

Usari, T. ;

Lanzalone, S. ;

Czibere, A. ;

Blum, J. L. ;

Martin, M. ;

Ettl, J. .

ANNALS OF ONCOLOGY, 2020, 31 (11) :1526-1535

[4] Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review [J].

Paracha, Noman ;

Thuresson, Per-Olof ;

Moreno, Santiago G. ;

MacGilchrist, Katherine S. .

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (05) :549-559

[5]

Zou D, BREAST

← 1 →